When a tissue is injured, it faces a critical choice: regenerate its original structure or heal via scarring. In healthy tissue, a tightly orchestrated dialogue unfolds. Immune cells rush in to clear debris, tissue-specific stem cells proliferate to replace lost functional units, and fibroblasts temporarily lay down an extracellular matrix (ECM) scaffold. Once repair is complete, the inflammatory signals subside, the fibroblasts quiet down, and normal architecture is restored.
Pathological fibrosis occurs when this cellular conversation gets stuck in a chronic, self-amplifying loop. Instead of promoting repair, a persistent inflammatory microenvironment continuously instructs mesenchymal cells (such as fibroblasts) to overproduce collagen, leading to organ failure. Recent research across multiple organs—including skeletal muscle, lungs, liver, heart, and skin—reveals that fibrosis is driven by specific, "rogue" immune cell subsets and altered molecular messengers that hijack normal tissue remodeling.
The Rogue Immune Microenvironment
To understand why a tissue stops regenerating and begins fibrosing, we must look at the specific immune cells dominating the injury site. Fibrosis is not caused by a generic inflammatory response, but rather by highly specialized, dysregulated immune subpopulations that actively drive fibroblast overactivity.
In chronic muscle diseases like Duchenne muscular dystrophy, macrophages are major culprits in ECM deposition. Using single-cell and spatial transcriptomics, Gérald Coulis et al. identified a distinct population of chronically activated muscle macrophages characterized by high expression of galectin-3 (Gal-3) and osteopontin (Spp1). These macrophages physically localize to fibrotic regions, acting as local signaling hubs that sustain fibrogenesis in Single-cell and spatial transcriptomics identify a macrophage population associated with skeletal muscle fibrosis. Similarly, in skin conditions characterized by excessive scarring, such as keloids, Zihan Li et al. demonstrated that the upregulation of the homeobox gene HOXC9 correlates tightly with aberrant macrophage infiltration, creating a pro-fibrotic microenvironment detailed in Identification of a potential bioinformatics-based biomarker in keloids and its correlation with immune infiltration.
This phenomenon extends beyond macrophages to adaptive immune cells. In fibrotic skin diseases, Cheng‐Cheng Deng et al. leveraged single-cell RNA sequencing to uncover a marked increase in T helper 17 (Th17) cells. The authors showed that these Th17 cells secrete interleukin-17A (IL-17A), which directly binds to fibroblasts to stimulate their proliferation and accelerate collagen production, as described in Single-cell RNA-seq reveals immune cell heterogeneity and increased Th17 cells in human fibrotic skin diseases.
Molecular Messengers: lncRNAs and Extracellular Vesicles
How do these rogue immune cells and remodeled tissues communicate over distance and across cell types? The answers lie in post-transcriptional regulators—specifically long noncoding RNAs (lncRNAs) and extracellular vesicles—that stabilize inflammatory signals or block pro-healing pathways.
In cholestatic liver injury, macrophages use specific noncoding transcripts to orchestrate tissue destruction. Xinbei Tian et al. demonstrated that the conditional depletion of macrophages significantly reduces liver fibrosis by disrupting a signaling axis governed by the lncRNA H19, providing a clear therapeutic target in Conditional depletion of macrophages ameliorates cholestatic liver injury and fibrosis via lncRNA-H19.
In the lungs, ectopic cell populations that emerge during tissue remodeling similarly deploy lncRNAs to recruit immune factors. Tsuyoshi Takashima et al. discovered that the lncRNA MIR205HG drives idiopathic pulmonary fibrosis (IPF) by interacting with genomic Alu elements. This interaction structurally stabilizes the mRNA of interleukin-33 (IL-33), a potent pro-inflammatory cytokine, thereby sustaining an environment that fosters fibrosis, as detailed in Involvement of lncRNA MIR205HG in idiopathic pulmonary fibrosis and IL-33 regulation via Alu elements.
[Ectopic/Immune Cells]
│
▼
lncRNAs (e.g., MIR205HG) ──► Stabilize Cytokine mRNAs (e.g., IL-33)
│
▼
[Persistent Inflammation] ──► Fibroblast Activation ──► Pathological Fibrosis
Communication can also occur via vesicular transport. In pressure overload-induced heart disease, Chaofu Li et al. found that microvascular endothelial cells release small extracellular vesicles containing Semaphorin3A (Sema3A). These vesicles competitively inhibit pro-angiogenic VEGFA signaling, causing microvascular rarefaction and downstream cardiac fibrosis, as shown in Semaphorin3A Exacerbates Cardiac Microvascular Rarefaction in Pressure Overload‐Induced Heart Disease.
Hyper-Migration and Cytokine Trans-Signaling
For fibrosis to become systemic or widespread, immune cells must efficiently traffic into injured tissues and engage in broad signaling networks.
In scleroderma interstitial lung disease (SSc-ILD), this trafficking mechanism is severely dysregulated. Elena Tourkina et al. established that monocytes from scleroderma patients suffer from a deficiency in caveolin-1. Because caveolin-1 normally restrains cell surface receptors, its absence leads to the over-expression of the chemokine receptor CXCR4. This molecular brake failure triggers hyper-migration of monocytes and circulating fibrocytes into lung tissue, accelerating fibrogenesis as documented in Altered monocyte and fibrocyte phenotype and function in scleroderma interstitial lung disease: reversal by caveolin-1 scaffolding domain peptide.
Once inside the tissue, these cells participate in destructive cytokine loops. Utilizing a humanized mouse model, Ian D. Odell et al. demonstrated that healthy hematopoietic stem cell transplants could mitigate scleroderma-induced skin fibrosis. The mechanism relies on downregulating IL-6 trans-signaling, proving that this specific systemic pathway is a critical driver of mesenchymal cell misbehavior and subsequent matrix deposition in IL-6 trans-signaling in a humanized mouse model of scleroderma.
The Regenerative Breakdown in Aging
The balance between fibrosis and regeneration shifts dramatically with age. As tissue-specific stem cells grow old, they lose their capacity to differentiate and instead begin actively contributing to the pro-fibrotic microenvironment.
In young skeletal muscle, regeneration relies on the precise post-transcriptional control of muscle stem cells (MuSCs). Wenjun Yang et al. identified a cascade where the RNA-binding proteins Msi2 and HuR repress the processing of microRNA-7a-1 (miR7a-1). This repression allows the translation of Cry2, a circadian regulator essential for myogenesis. In aged muscle, this axis breaks down: Msi2 levels fall, mature miR7a-1 accumulates, and MuSCs fail to differentiate, leaving the tissue vulnerable to fibrotic replacement, as shown in Msi2‐mediated MiR7a‐1 processing repression promotes myogenesis.
Furthermore, senescent stem cells do not merely fail to function; they actively secrete harmful factors. Faqin Li et al. discovered that aged, senescent MuSCs secrete high levels of CCN2 (Connective Tissue Growth Factor), which directly promotes muscle fibrosis and blocks repair. Crucially, the authors demonstrated that this degenerative state can be counteracted: aerobic exercise or chemical AMPK activation suppresses CCN2 secretion, restoring the regenerative microenvironment in Aerobic exercise suppresses CCN2 secretion from senescent muscle stem cells and boosts muscle regeneration in aged mice.
By mapping these interlocking pathways—from the recruitment of rogue macrophages and Th17 cells to lncRNA stabilization and senescent stem cell secretions—researchers are shifting the view of fibrosis from an inevitable consequence of injury to a highly regulated, and potentially reversible, signaling network.
Key Foundational Work
Altered monocyte and fibrocyte phenotype and function in scleroderma interstitial lung disease: reversal by caveolin-1 scaffolding domain peptide (2011) — contributed 2 concept elements to this direction.
Msi2‐mediated MiR7a‐1 processing repression promotes myogenesis (2021) — contributed 2 concept elements to this direction.
Conditional depletion of macrophages ameliorates cholestatic liver injury and fibrosis via lncRNA-H19 (2021) — contributed 1 concept elements to this direction.